Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease
- PMID: 29470286
- PMCID: PMC5916321
- DOI: 10.1097/MPG.0000000000001926
Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease
Abstract
Background and objectives: Nonalcoholic fatty liver disease (NAFLD) disproportionately affects Hispanic boys. Further, obesity and insulin resistance are major risk factors for NAFLD. No gene localization studies had been performed on children with biopsy-proven NAFLD. This study aims to identify genomic variants associated with increased adiposity and insulin resistance in a population of children with varying histologic severity of NAFLD.
Methods: We conducted a genome-wide association scan (GWAS) including 624,297 single-nucleotide polymorphisms (SNPs) distributed among all 22 autosomal chromosomes in 234 Hispanic boys (up to 18 years of age) who were consecutively recruited in a prospective cohort study in the Nonalcoholic Steatohepatitis Clinical Research Network Studies. Traits were examined quantitatively using linear regression. SNPs with P value <10 and a minor allele frequency >5% were considered potentially significant.
Results: Evaluated subjects had a median age of 12.0 years, body mass index (BMI) of 31.4, and hemoglobin A1C (Hgb A1C) of 5.3. The prevalence of NAFL, borderline NASH, and definite NASH were 23%, 53%, and 22%, respectively. The GWAS identified 10 SNPs that were associated with BMI z score, 6 within chromosome 2, and 1 within CAMK1D, which has a potential role in liver gluconeogenesis. In addition, the GWAS identified 9 novel variants associated with insulin resistance: HOMA-IR (6) and HbA1c (3).
Conclusions: This study of Hispanic boys with biopsy-proven NAFLD with increased risk for the metabolic syndrome revealed novel genetic variants that are associated with obesity and insulin resistance.
Trial registration: ClinicalTrials.gov NCT01061684.
Conflict of interest statement
Conflicts of Interest:
John C Rausch, Joel E Lavine, Xiuqing Guo, Soonil Kwon, Jeffrey Schwimmer, Jean Molleston, Rohit Loomba, Elizabeth M Brunt, Yii-Der Ida Chen, Mark O Goodarzi, Kent D Taylor, Katherine P Yates, Aynur Unalp-Arida, and Jerome I Rotter: none
Naga P Chalasani: Dr. Chalasani has consulting agreements and research grants with pharmaceutical industry but none of them represent a conflict for this particular paper.
Figures
References
-
- Ovchinsky N, Lavine JE. A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease. Semin Liver Dis. 2012;32(4):317–24. - PubMed
-
- Schwimmer JB, Deutsch R, Rauch JB, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143(4):500–5. - PubMed
-
- Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, et al. Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract. 2014;8(1):e1–e114. - PubMed
-
- Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388–93. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- UL1 RR025761/RR/NCRR NIH HHS/United States
- U01 DK061732/DK/NIDDK NIH HHS/United States
- U01 DK061731/DK/NIDDK NIH HHS/United States
- U01 DK061718/DK/NIDDK NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- U01 DK061730/DK/NIDDK NIH HHS/United States
- U01 DK061728/DK/NIDDK NIH HHS/United States
- UL1 RR025014/RR/NCRR NIH HHS/United States
- U01 DK061738/DK/NIDDK NIH HHS/United States
- UL1 RR029887/RR/NCRR NIH HHS/United States
- U01 DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061713/DK/NIDDK NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- M01 RR000188/RR/NCRR NIH HHS/United States
- UL1 RR025741/RR/NCRR NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- UL1 RR031990/RR/NCRR NIH HHS/United States
- U01 DK061734/DK/NIDDK NIH HHS/United States
- UL1 RR031980/RR/NCRR NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- S10 RR025055/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
